150 related articles for article (PubMed ID: 10772385)
1. Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists.
Lippert U; Möller A; Welker P; Artuc M; Henz BM
Exp Dermatol; 2000 Apr; 9(2):118-24. PubMed ID: 10772385
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines.
Lippert U; Krüger-Krasagakes S; Möller A; Kiessling U; Czarnetzki BM
Exp Dermatol; 1995 Aug; 4(4 Pt 2):272-6. PubMed ID: 8528601
[TBL] [Abstract][Full Text] [Related]
3. Short-term and long-term cytokine release by mouse bone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefeldin A.
Zhu FG; Gomi K; Marshall JS
J Immunol; 1998 Sep; 161(5):2541-51. PubMed ID: 9725254
[TBL] [Abstract][Full Text] [Related]
4. The effect of H1 and H2 receptor blockers on immunological and nonspecific histamine release from isolated target cells.
Hofman J; Siergiejko Z; Kuczewska B; Chyrek-Borowska S
Arch Immunol Ther Exp (Warsz); 1984; 32(5):599-604. PubMed ID: 6085468
[TBL] [Abstract][Full Text] [Related]
5. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells.
Kempuraj D; Huang M; Kandere-Grzybowska K; Basu S; Boucher W; Letourneau R; Athanassiou A; Theoharides TC
Int Arch Allergy Immunol; 2003 Nov; 132(3):231-9. PubMed ID: 14646384
[TBL] [Abstract][Full Text] [Related]
6. Production of interleukin-6 by human mast cells and basophilic cells.
Krüger-Krasagakes S; Möller A; Kolde G; Lippert U; Weber M; Henz BM
J Invest Dermatol; 1996 Jan; 106(1):75-9. PubMed ID: 8592085
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of budesonide, desloratadine and dexamethasone on cytokine release from human mast cell line (HMC-1).
Zhao Y; Leung PC; Woo KS; Chen GG; Wong YO; Liu SX; van Hasselt CA
Inflamm Res; 2004 Dec; 53(12):664-9. PubMed ID: 15654514
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
Schroeder JT; Schleimer RP; Lichtenstein LM; Kreutner W
Clin Exp Allergy; 2001 Sep; 31(9):1369-77. PubMed ID: 11591186
[TBL] [Abstract][Full Text] [Related]
9. Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils.
Hosoda M; Yamaya M; Suzuki T; Yamada N; Kamanaka M; Sekizawa K; Butterfield JH; Watanabe T; Nishimura H; Sasaki H
J Immunol; 2002 Aug; 169(3):1482-91. PubMed ID: 12133975
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional cytokine expression by human mast cells: regulation by T cell membrane contact and glucocorticoids.
Krishnaswamy G; Lakshman T; Miller AR; Srikanth S; Hall K; Huang SK; Suttles J; Smith JK; Stout R
J Interferon Cytokine Res; 1997 Mar; 17(3):167-76. PubMed ID: 9085942
[TBL] [Abstract][Full Text] [Related]
11. [Effects of budesonide, desloratadine and dexamethasone on interleukine-4 release and expression from human mast cell line].
Zhao Y; van Hasselt CA; Woo KS; Wong YO; Liang CY; Leung PC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Feb; 40(2):124-7. PubMed ID: 16429733
[TBL] [Abstract][Full Text] [Related]
12. Effects of antihistamines on isolated human lung mast cells, basophil leucocytes and erythrocytes.
Lau HY; Pearce FL
Agents Actions; 1989 Apr; 27(1-2):83-5. PubMed ID: 2473642
[TBL] [Abstract][Full Text] [Related]
13. Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids.
Lippert U; Welker P; Krüger-Krasagakes S; Möller A; Henz BM
Skin Pharmacol; 1996; 9(2):93-8. PubMed ID: 8722602
[TBL] [Abstract][Full Text] [Related]
14. The effect of mizolastine on expression of vascular endothelial cell growth factor, tumour necrosis factor-alpha and keratinocyte-derived chemokine in murine mast cells, compared with dexamethasone and loratadine.
Xia Q; Yang S; Zhang SQ; Chen B; Wang DB; Zhu QX; Wang Y; Yan KL; He PP; Zhang XJ
Clin Exp Dermatol; 2005 Mar; 30(2):165-70. PubMed ID: 15725247
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-4 and interleukin-13 release from immunologically activated human basophils due to the actions of anti-allergic drugs.
Gibbs BF; Vollrath IB; Albrecht C; Amon U; Wolff HH
Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):573-8. PubMed ID: 9650812
[TBL] [Abstract][Full Text] [Related]
16. Histamine-stimulated cytokine secretion from human conjunctival epithelial cells: inhibition by the histamine H1 antagonist emedastine.
Weimer LK; Gamache DA; Yanni JM
Int Arch Allergy Immunol; 1998 Apr; 115(4):288-93. PubMed ID: 9566351
[TBL] [Abstract][Full Text] [Related]
17. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
18. FK506 inhibition of histamine release and cytokine production by mast cells and basophils.
Sengoku T; Kishi S; Sakuma S; Ohkubo Y; Goto T
Int J Immunopharmacol; 2000 Mar; 22(3):189-201. PubMed ID: 10685002
[TBL] [Abstract][Full Text] [Related]
19. Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
Vasiadi M; Kalogeromitros D; Kempuraj D; Clemons A; Zhang B; Chliva C; Makris M; Wolfberg A; House M; Theoharides TC
Int Arch Allergy Immunol; 2010; 151(1):38-45. PubMed ID: 19672095
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells.
Smith SJ; Piliponsky AM; Rosenhead F; Elchalal U; Nagler A; Levi-Schaffer F
Clin Exp Allergy; 2002 Jun; 32(6):906-13. PubMed ID: 12047438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
